The emerging role of AMP-activated protein kinase in cholestatic liver diseases

被引:24
作者
Li, Xiaojiaoyang [1 ,2 ]
Liu, Runping [2 ]
Zhang, Luyong [1 ,3 ]
Jiang, Zhenzhou [1 ,4 ]
机构
[1] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing, Jiangsu, Peoples R China
[2] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA
[3] Guangdong Pharmaceut Univ, Sch Pharm, Ctr Drug Screening & Pharmacodynam Evaluat, Guangzhou, Guangdong, Peoples R China
[4] China Pharmaceut Univ, Key Lab Drug Qual Control & Pharmacovigilance, Minist Educ, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
AMP-activated protein kinase; Cholestasis; Fibrosis; Liver injury; FARNESOID X RECEPTOR; BILE-ACID-HOMEOSTASIS; HEPATIC STELLATE CELLS; 17-ALPHA-ETHINYLESTRADIOL-INDUCED CHOLESTASIS; OBSTRUCTIVE-CHOLESTASIS; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; SIGNALING PATHWAY; IN-VIVO; INJURY;
D O I
10.1016/j.phrs.2017.09.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AMP-activated protein kinase (AMPK), recognized as an energy sensor with three heterotrimeric subunits (alpha, beta and gamma), not only maintains basal intracellular adenosine triphosphate levels but also regulates energy-intensive pathological responses, such as neurodegenerative and metabolic diseases, through multiple signaling pathways. Recent studies open a new direction for AMPK research and demonstrate that AMPK is a critical player in the pathogenesis of cholestatic liver injury and plays paradoxical roles in the regulation of different pathological processes, including the disruption of bile acid homeostasis and the regulation of hepatic polarity, inflammation and fibrosis. In the present review, we summarize recent findings that implicate AMPK-mediated signaling pathways in the pathogenesis of cholestatic liver injury. These findings provide novel insight regarding the potential use of AMPK as a therapeutic target for the treatment of cholestatic liver injury. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 87 条
[51]   Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice [J].
Meng, Qiang ;
Chen, Xinli ;
Wang, Changyuan ;
Liu, Qi ;
Sun, Huijun ;
Sun, Pengyuan ;
Huo, Xiaokui ;
Liu, Zhihao ;
Yao, Jihong ;
Liu, Kexin .
PHARMACEUTICAL RESEARCH, 2015, 32 (11) :3688-3698
[52]   The AMPK signalling pathway coordinates cell growth, autophagy and metabolism [J].
Mihaylova, Maria M. ;
Shaw, Reuben J. .
NATURE CELL BIOLOGY, 2011, 13 (09) :1016-1023
[53]   Essential roles of myosin phosphatase in the maintenance of epithelial cell integrity of Drosophila imaginal disc cells [J].
Mitonaka, Tomoaki ;
Muramatsu, Yoshiyuki ;
Sugiyama, Shin ;
Mizuno, Tomoaki ;
Nishida, Yasuyoshi .
DEVELOPMENTAL BIOLOGY, 2007, 309 (01) :78-86
[54]   AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation [J].
Nakano, Atsushi ;
Kato, Hisakazu ;
Watanabe, Takashi ;
Min, Kyung-Duk ;
Yamazaki, Satoru ;
Asano, Yoshihiro ;
Seguchi, Osamu ;
Higo, Shuichiro ;
Shintani, Yasunori ;
Asanuma, Hiroshi ;
Asakura, Masanori ;
Minamino, Tetsuo ;
Kaibuchi, Kozo ;
Mochizuki, Naoki ;
Kitakaze, Masafumi ;
Takashima, Seiji .
NATURE CELL BIOLOGY, 2010, 12 (06) :583-U139
[55]  
Nammour Fadel E, 2003, Endocr Pract, V9, P307
[56]   Farnesoid X Receptor Activation by Chenodeoxycholic Acid Induces Detoxifying Enzymes through AMP-Activated Protein Kinase and Extracellular Signal-Regulated Kinase 1/2-Mediated Phosphorylation of CCAAT/Enhancer Binding Protein β [J].
Noh, Kyoung ;
Kim, Young Mi ;
Kim, Young Woo ;
Kim, Sang Geon .
DRUG METABOLISM AND DISPOSITION, 2011, 39 (08) :1451-1459
[57]   Protective effects of rutin on liver injury induced by biliary obstruction in rats [J].
Pan, Pin-Ho ;
Lin, Shih-Yi ;
Wang, Ya-Yu ;
Chen, Wen-Ying ;
Chuang, Yu-Han ;
Wu, Chih-Cheng ;
Chen, Chun-Jung .
FREE RADICAL BIOLOGY AND MEDICINE, 2014, 73 :106-116
[58]   Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics [J].
Patel, Amitkumar ;
Seetharam, Anil .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2016, 6 (04) :311-318
[59]   Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis [J].
Pollheimer, Marion J. ;
Fickert, Peter ;
Stieger, Bruno .
MOLECULAR ASPECTS OF MEDICINE, 2014, 37 :35-56
[60]   Flufenamic acid protects against intestinal fluid secretion and barrier leakage in a mouse model of Vibrio cholerae infection through NF-κB inhibition and AMPK activation [J].
Pongkorpsakol, Pawin ;
Satitsri, Saravut ;
Wongkrasant, Preedajit ;
Chittavanich, Pamorn ;
Kittayaruksakul, Suticha ;
Srimanote, Potjanee ;
Chatsudthipong, Varanuj ;
Muanprasat, Chatchai .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 798 :94-104